Information Provided By:
Fly News Breaks for May 3, 2019
ACHN
May 3, 2019 | 05:06 EDT
Barclays analyst Geoffrey Meacham downgraded Achillion Pharmaceuticals to Underweight from Equal Weight and cut his price target for the shares to $2.50 from $5.
News For ACHN From the Last 2 Days
There are no results for your query ACHN